Overview In this General Development role, you guide hemato-oncology programs from early design to closeout, ensuring rigorous risk–benefit evaluation and patient safety. You collaborate with Clinical Operations and cross-functional teams to shape protocols, engage investigators, and translate data into decisive actions that keep trials on track. You will lead process improvements and contribute to cross-asset initiatives across multiple indications and stages.

This position offers impact by accelerating trials, advancing transformative therapies, and shaping development strategy in oncology.

Responsabilidades

Ensure risk-benefit balance and safety standards across clinical studies in accordance with FDA, EMA, ICH, GCP, and AZ SOPs

Contribute to design and implementation of hematology-oncology projects with cross-functional teams

Develop program strategy and defend business cases for governance approvals

Provide clinical input to study design through collaboration with investigators, KEEs, sites, and internal stakeholders

Review opportunities and ESRs; support interactions with global medical affairs, marketing,



and commercial teams

Coordinate investigator and monitor training; respond to site inquiries regarding ICF, protocol, and EC/IRB questions

Assist in regulatory submission components (clinical development plans, dossiers, BLAs, INDs, safety reports)

Present and defend protocols and development plans at governance forums

Act as Medical Monitor for safety oversight in Phase I–III trials

Support implementation of R&D; policies and department-wide initiatives

Contribute to cross-functional alignment during early clinical development

Maintain on-site presence in Barcelona (three days/week) and enable timely cross-functional collaboration

Requisitos principales MD or international equivalent

Medical oncology clinical training

Fluency in English cross-functional collaboration scientific rigor leadership and coordination

Good Clinical Practice (GCP) knowledge regulatory submission processes (Dossiers, BLAs, INDs)

clinical trials methodology

📌 Global Development Associate Medical Director (Barcelona)
🏢 AstraZeneca
📍 Barcelona